Science Library
The Company does not promote or sell any of its dietary supplement products for the diagnosis, treatment, cure, prevention or mitigation of any disease or class of diseases. The Company provides the following information pursuant to Section 5, a special provision of the Dietary Supplement Health and Education Act of 1994, that allows certain scientific information to be made available in connection with the sale of dietary supplements.
The Research
Research has shown that when the body’s estrogen metabolism is unbalanced, the estrogen metabolites can react with DNA and thereby are prone to start the process that may lead to breast and prostate cancer. Renowned scientists Dr. Ercole Cavalieri and Dr. Eleanor Rogan, who have been involved with these scientific findings and research for more than three decades, have published their findings in the following journals: International Journal of Cancer; Cancer Prevention Research; Breast Cancer: Basic and Clinical Research; Prostate; Journal of Steroid Biochemistry and Molecular Biology; Future Oncology.
Science Library Documents
The following landmark published articles
are written on findings related to product development, its research
and scientists.
- Resveratrol Prevents Estrogen-DNA Adduct Formation and Neoplastic Transformation in MCF-10F Cells
- Depurinating estrogen–DNA adducts in the etiology and prevention of breast and other human cancers
- Inhibition of catechol-O-methyltransferase increases estrogen–DNA adduct formation
- Potential Biomarker for Early Risk Assessment of Prostate Cancer
- The Greater Reactivity of Estradiol-3,4-quinone vs Estradiol-2,3-quinone with DNA in the Formation of Depurinating Adducts: Implications for Tumor-Initiating Activity
- Inhibition of Depurinating Estrogen-DNA Adduct Formation by Natural Compounds